resistance on targeted therapy: questions patients should ask-targeted therapies in lung cancer 2023
Published 1 year ago • 95 plays • Length 6:04Download video MP4
Download video MP3
Similar videos
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
1:49
q&a: when should a patient do biomarker retesting? - targeted therapies in lung cancer 2023
-
6:00
q&a: does radiation increase toxicity for patients on tt? - targeted therapies in lung cancer 2023
-
4:41
q&a: what do oncologists do for patients with co-alterations?-targeted therapies in lung cancer 2023
-
4:57
adding to targeted therapy: current statistics and biology - targeted therapies in lung cancer 2023
-
2:00
why some patients remain on tkis without acquiring resistance? - targeted therapies in lung cancer
-
3:41
q&a: what can patients do to close the biomarker testing gap?-targeted therapies in lung cancer 2023
-
4:48
biomarker driven therapy for nsclc - targeted therapies in lung cancer 2023
-
3:33
current recommendations and best practices for biomarker testing - targeted therapies in lung cancer
-
4:04
challenges of targeted kras treatment & current treatments - targeted therapies in lung cancer 2023
-
2:51
neoadjuvant treatment for patients with nsclc - targeted therapies in lung cancer 2023
-
1:32
q&a: am i increasing my lung cancer risk with campfires? - targeted therapies in lung cancer 2023
-
2:36
the future of local therapy - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
10:03
kras nsclc: details and diagnosis - targeted therapies in lung cancer 2023
-
3:46
q&a: how do oncologists approach compound egfr mutations? - targeted therapies in lung cancer 2023
-
7:33
local therapy for patients after frontline therapy - targeted therapies in lung cancer 2023
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
2:43
nrg1 fusions: treatment options - targeted therapies in lung cancer 2023